ID   CRBG1_HUMAN             Reviewed;        1723 AA.
AC   Q9Y4K1; B4DU04; O00296; Q5VWJ2;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 3.
DT   03-AUG-2022, entry version 179.
DE   RecName: Full=Beta/gamma crystallin domain-containing protein 1 {ECO:0000312|HGNC:HGNC:356};
DE   AltName: Full=Absent in melanoma 1 protein {ECO:0000303|PubMed:9096375};
GN   Name=CRYBG1 {ECO:0000312|HGNC:HGNC:356};
GN   Synonyms=AIM1 {ECO:0000303|PubMed:9096375};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-86 (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 87-1723, AND VARIANTS PRO-293; ALA-1196 AND TYR-1395.
RC   TISSUE=Liver;
RX   PubMed=9096375; DOI=10.1073/pnas.94.7.3229;
RA   Ray M.E., Wistow G., Su Y.A., Meltzer P.S., Trent J.M.;
RT   "AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is
RT   associated with the control of tumorigenicity in human malignant
RT   melanoma.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:3229-3234(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; SER-329 AND THR-525, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; SER-81 AND SER-348, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   STRUCTURE BY NMR OF 1416-1495.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fifth crystallin domain of the non-lens protein,
RT   absent in melanoma 1.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.88 ANGSTROMS) OF 1022-1117.
RX   PubMed=18582473; DOI=10.1016/j.jmb.2008.06.019;
RA   Aravind P., Wistow G., Sharma Y., Sankaranarayanan R.;
RT   "Exploring the limits of sequence and structure in a variant betagamma-
RT   crystallin domain of the protein absent in melanoma-1 (AIM1).";
RL   J. Mol. Biol. 381:509-518(2008).
CC   -!- FUNCTION: May function as suppressor of malignant melanoma. It may
CC       exert its effects through interactions with the cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y4K1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y4K1-2; Sequence=VSP_056580, VSP_056581;
CC   -!- SIMILARITY: Belongs to the beta/gamma-crystallin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U83116; AAB53792.1; -; Genomic_DNA.
DR   EMBL; U83115; AAB53791.1; -; mRNA.
DR   EMBL; AK300443; BAG62166.1; -; mRNA.
DR   EMBL; AL359292; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390074; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48412.1; -; Genomic_DNA.
DR   CCDS; CCDS34506.1; -. [Q9Y4K1-1]
DR   RefSeq; NP_001615.2; NM_001624.3. [Q9Y4K1-1]
DR   PDB; 2DAD; NMR; -; A=1416-1495.
DR   PDB; 3CW3; X-ray; 1.88 A; A=1022-1117.
DR   PDB; 6VRO; X-ray; 2.45 A; B=716-741.
DR   PDBsum; 2DAD; -.
DR   PDBsum; 3CW3; -.
DR   PDBsum; 6VRO; -.
DR   AlphaFoldDB; Q9Y4K1; -.
DR   SMR; Q9Y4K1; -.
DR   BioGRID; 106705; 101.
DR   ELM; Q9Y4K1; -.
DR   IntAct; Q9Y4K1; 18.
DR   MINT; Q9Y4K1; -.
DR   STRING; 9606.ENSP00000358062; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   GlyConnect; 2023; 2 N-Linked glycans (1 site).
DR   GlyGen; Q9Y4K1; 3 sites, 4 N-linked glycans (1 site), 1 O-linked glycan (2 sites).
DR   iPTMnet; Q9Y4K1; -.
DR   PhosphoSitePlus; Q9Y4K1; -.
DR   SwissPalm; Q9Y4K1; -.
DR   BioMuta; CRYBG1; -.
DR   DMDM; 76800646; -.
DR   EPD; Q9Y4K1; -.
DR   jPOST; Q9Y4K1; -.
DR   MassIVE; Q9Y4K1; -.
DR   MaxQB; Q9Y4K1; -.
DR   PaxDb; Q9Y4K1; -.
DR   PeptideAtlas; Q9Y4K1; -.
DR   PRIDE; Q9Y4K1; -.
DR   ProteomicsDB; 5139; -.
DR   ProteomicsDB; 86224; -. [Q9Y4K1-1]
DR   DNASU; 202; -.
DR   GeneID; 202; -.
DR   KEGG; hsa:202; -.
DR   UCSC; uc003prh.4; human. [Q9Y4K1-1]
DR   CTD; 202; -.
DR   DisGeNET; 202; -.
DR   GeneCards; CRYBG1; -.
DR   HGNC; HGNC:356; CRYBG1.
DR   MIM; 601797; gene.
DR   neXtProt; NX_Q9Y4K1; -.
DR   PharmGKB; PA24649; -.
DR   eggNOG; ENOG502QUA4; Eukaryota.
DR   HOGENOM; CLU_002648_0_0_1; -.
DR   InParanoid; Q9Y4K1; -.
DR   PhylomeDB; Q9Y4K1; -.
DR   TreeFam; TF331078; -.
DR   PathwayCommons; Q9Y4K1; -.
DR   SignaLink; Q9Y4K1; -.
DR   BioGRID-ORCS; 202; 8 hits in 1054 CRISPR screens.
DR   ChiTaRS; AIM1; human.
DR   EvolutionaryTrace; Q9Y4K1; -.
DR   GeneWiki; AIM1; -.
DR   GenomeRNAi; 202; -.
DR   Pharos; Q9Y4K1; Tbio.
DR   PRO; PR:Q9Y4K1; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q9Y4K1; protein.
DR   Genevisible; Q9Y4K1; HS.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   CDD; cd00161; RICIN; 1.
DR   InterPro; IPR001064; Beta/gamma_crystallin.
DR   InterPro; IPR011024; G_crystallin-like.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00030; Crystall; 6.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   PRINTS; PR01367; BGCRYSTALLIN.
DR   SMART; SM00458; RICIN; 1.
DR   SMART; SM00247; XTALbg; 6.
DR   SUPFAM; SSF49695; SSF49695; 3.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   PROSITE; PS50915; CRYSTALLIN_BETA_GAMMA; 12.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Lectin; Phosphoprotein;
KW   Reference proteome; Repeat.
FT   CHAIN           1..1723
FT                   /note="Beta/gamma crystallin domain-containing protein 1"
FT                   /id="PRO_0000057609"
FT   DOMAIN          1022..1061
FT                   /note="Beta/gamma crystallin 'Greek key' 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1062..1117
FT                   /note="Beta/gamma crystallin 'Greek key' 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1123..1163
FT                   /note="Beta/gamma crystallin 'Greek key' 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1164..1206
FT                   /note="Beta/gamma crystallin 'Greek key' 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1218..1270
FT                   /note="Beta/gamma crystallin 'Greek key' 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1271..1313
FT                   /note="Beta/gamma crystallin 'Greek key' 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1319..1361
FT                   /note="Beta/gamma crystallin 'Greek key' 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1362..1404
FT                   /note="Beta/gamma crystallin 'Greek key' 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1415..1452
FT                   /note="Beta/gamma crystallin 'Greek key' 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1453..1496
FT                   /note="Beta/gamma crystallin 'Greek key' 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1502..1542
FT                   /note="Beta/gamma crystallin 'Greek key' 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1543..1584
FT                   /note="Beta/gamma crystallin 'Greek key' 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00028"
FT   DOMAIN          1586..1719
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REGION          1..266
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          280..299
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          315..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          429..481
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          518..539
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          633..693
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          863..894
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          908..940
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        172..197
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        248..266
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        359..379
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        447..467
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        633..691
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        922..940
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         75
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         81
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         525
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   VAR_SEQ         1..26
FT                   /note="MEKRSSGRRSGRRRGSQKSTDSPGAD -> MQKPKTVAWENLGPEMSALGTA
FT                   FSRE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056580"
FT   VAR_SEQ         27..1207
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056581"
FT   VARIANT         267
FT                   /note="G -> D (in dbSNP:rs11968933)"
FT                   /id="VAR_055687"
FT   VARIANT         293
FT                   /note="Q -> P (in dbSNP:rs1159148)"
FT                   /evidence="ECO:0000269|PubMed:9096375"
FT                   /id="VAR_055688"
FT   VARIANT         491
FT                   /note="C -> R (in dbSNP:rs3747787)"
FT                   /id="VAR_055689"
FT   VARIANT         1096
FT                   /note="L -> V (in dbSNP:rs1350902)"
FT                   /id="VAR_055690"
FT   VARIANT         1196
FT                   /note="E -> A (in dbSNP:rs783396)"
FT                   /evidence="ECO:0000269|PubMed:9096375"
FT                   /id="VAR_055691"
FT   VARIANT         1395
FT                   /note="C -> Y (in dbSNP:rs2297970)"
FT                   /evidence="ECO:0000269|PubMed:9096375"
FT                   /id="VAR_055692"
FT   VARIANT         1445
FT                   /note="T -> S (in dbSNP:rs1676015)"
FT                   /id="VAR_055693"
FT   STRAND          1023..1028
FT                   /evidence="ECO:0007829|PDB:3CW3"
FT   STRAND          1037..1039
FT                   /evidence="ECO:0007829|PDB:3CW3"
FT   STRAND          1053..1069
FT                   /evidence="ECO:0007829|PDB:3CW3"
FT   TURN            1070..1072
FT                   /evidence="ECO:0007829|PDB:3CW3"
FT   STRAND          1073..1079
FT                   /evidence="ECO:0007829|PDB:3CW3"
FT   STRAND          1081..1088
FT                   /evidence="ECO:0007829|PDB:3CW3"
FT   HELIX           1094..1096
FT                   /evidence="ECO:0007829|PDB:3CW3"
FT   STRAND          1098..1100
FT                   /evidence="ECO:0007829|PDB:3CW3"
FT   STRAND          1112..1116
FT                   /evidence="ECO:0007829|PDB:3CW3"
FT   STRAND          1416..1422
FT                   /evidence="ECO:0007829|PDB:2DAD"
FT   TURN            1423..1425
FT                   /evidence="ECO:0007829|PDB:2DAD"
FT   STRAND          1426..1434
FT                   /evidence="ECO:0007829|PDB:2DAD"
FT   HELIX           1440..1442
FT                   /evidence="ECO:0007829|PDB:2DAD"
FT   STRAND          1446..1460
FT                   /evidence="ECO:0007829|PDB:2DAD"
FT   STRAND          1472..1477
FT                   /evidence="ECO:0007829|PDB:2DAD"
FT   HELIX           1478..1481
FT                   /evidence="ECO:0007829|PDB:2DAD"
FT   STRAND          1491..1495
FT                   /evidence="ECO:0007829|PDB:2DAD"
SQ   SEQUENCE   1723 AA;  188676 MW;  F4137765BCE039D5 CRC64;
     MEKRSSGRRS GRRRGSQKST DSPGADAELP ESAARDDAVF DDEVAPNAAS DNASAEKKVK
     SPRAALDGGV ASAASPESKP SPGTKGQLRG ESDRSKQPPP ASSPTKRKGR SRALEAVPAP
     PASGPRAPAK ESPPKRVPDP SPVTKGTAAE SGEEAARAIP RELPVKSSSL LPEIKPEHKR
     GPLPNHFNGR AEGGRSRELG RAAGAPGASD ADGLKPRNHF GVGRSTVTTK VTLPAKPKHV
     ELNLKTPKNL DSLGNEHNPF SQPVHKGNTA TKISLFENKR TNSSPRHTDI RGQRNTPASS
     KTFVGRAKLN LAKKAKEMEQ PEKKVMPNSP QNGVLVKETA IETKVTVSEE EILPATRGMN
     GDSSENQALG PQPNQDDKAD VQTDAGCLSE PVASALIPVK DHKLLEKEDS EAADSKSLVL
     ENVTDTAQDI PTTVDTKDLP PTAMPKPQHT FSDSQSPAES SPGPSLSLSA PAPGDVPKDT
     CVQSPISSFP CTDLKVSENH KGCVLPVSRQ NNEKMPLLEL GGETTPPLST ERSPEAVGSE
     CPSRVLVQVR SFVLPVESTQ DVSSQVIPES SEVREVQLPT CHSNEPEVVS VASCAPPQEE
     VLGNEHSHCT AELAAKSGPQ VIPPASEKTL PIQAQSQGSR TPLMAESSPT NSPSSGNHLA
     TPQRPDQTVT NGQDSPASLL NISAGSDDSV FDSSSDMEKF TEIIKQMDSA VCMPMKRKKA
     RMPNSPAPHF AMPPIHEDHL EKVFDPKVFT FGLGKKKESQ PEMSPALHLM QNLDTKSKLR
     PKRASAEQSV LFKSLHTNTN GNSEPLVMPE INDKENRDVT NGGIKRSRLE KSALFSSLLS
     SLPQDKIFSP SVTSVNTMTT AFSTSQNGSL SQSSVSQPTT EGAPPCGLNK EQSNLLPDNS
     LKVFNFNSSS TSHSSLKSPS HMEKYPQKEK TKEDLDSRSN LHLPETKFSE LSKLKNDDME
     KANHIESVIK SNLPNCANSD TDFMGLFKSS RYDPSISFSG MSLSDTMTLR GSVQNKLNPR
     PGKVVIYSEP DVSEKCIEVF SDIQDCSSWS LSPVILIKVV RGCWILYEQP NFEGHSIPLE
     EGELELSGLW GIEDILERHE EAESDKPVVI GSIRHVVQDY RVSHIDLFTE PEGLGILSSY
     FDDTEEMQGF GVMQKTCSMK VHWGTWLIYE EPGFQGVPFI LEPGEYPDLS FWDTEEAYIG
     SMRPLKMGGR KVEFPTDPKV VVYEKPFFEG KCVELETGMC SFVMEGGETE EATGDDHLPF
     TSVGSMKVLR GIWVAYEKPG FTGHQYLLEE GEYRDWKAWG GYNGELQSLR PILGDFSNAH
     MIMYSEKNFG SKGSSIDVLG IVANLKETGY GVKTQSINVL SGVWVAYENP DFTGEQYILD
     KGFYTSFEDW GGKNCKISSV QPICLDSFTG PRRRNQIHLF SEPQFQGHSQ SFEETTSQID
     DSFSTKSCRV SGGSWVVYDG ENFTGNQYVL EEGHYPCLSA MGCPPGATFK SLRFIDVEFS
     EPTIILFERE DFKGKKIELN AETVNLRSLG FNTQIRSVQV IGGIWVTYEY GSYRGRQFLL
     SPAEVPNWYE FSGCRQIGSL RPFVQKRIYF RLRNKATGLF MSTNGNLEDL KLLRIQVMED
     VGADDQIWIY QEGCIKCRIA EDCCLTIVGS LVTSGSKLGL ALDQNADSQF WSLKSDGRIY
     SKLKPNLVLD IKGGTQYDQN HIILNTVSKE KFTQVWEAMV LYT
//
